Oncology Today Podcaster

Dr Jacob Laubach from the Dana-Farber Cancer Institute discusses key presentations in multiple myeloma from the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice

Dr John Allan from Weill Cornell Medicine in New York City discusses the most important chronic lymphocytic leukemia studies presented at ASH 2022. CME information and select publications here.Av Research To Practice

Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha, Nebraska, discusses the most important lymphoma studies presented at the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice

Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York City discusses the management of desmoid tumors. CME information and select publications here.Av Research To Practice

Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer. CME information and select publications here.Av Research To Practice

Dr Edward Garon from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, discusses the management of NSCLC in patients who do not have actionable activating mutations. CME information and select publications here.Av Research To Practice

Dr Srdan Verstovsek from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses new data with myeloproliferative neoplasms presented at the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice

Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York City discusses recent data from clinical trials evaluating targeted therapies for diffuse large B-cell lymphoma. CME information and select publications here.Av Research To Practice

Dr Richard Stone from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses new data in acute myeloid leukemia and myelodysplastic syndromes presented at the 2022 ASH Annual Meeting. CME information and select publications here.Av Research To Practice

Dr Erica Mayer from the Dana-Farber Cancer Institute in Boston, Massachusetts and Dr Ruth O'Regan from the University of Rochester in Rochester, New York discuss new developments in ER-positive breast cancer. CME information and select publications here.Av Research To Practice

Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer. CME information and select publications here.Av Research To Practice

Dr Manish Shah from Weill Cornell Medicine in New York City discusses current approaches to the management of upper GI malignancies and the potential future role of novel therapies for patients with these cancers. CME information and select publications here.Av Research To Practice

Dr Scott Tagawa from Weill Cornell Medicine Sandra and Edward Meyer Cancer Center in New York, New York discusses current treatments and management strategies for metastatic urothelial bladder cancer. CME information and select publications here.Av Research To Practice

Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer. CME information and select publications here.Av Research To Practice

Dr Omid Hamid from the Angeles Clinic and Research Institute in Los Angeles, California, discusses novel immunotherapies and combination treatments for patients with metastatic melanoma. CME information and select publications here.Av Research To Practice

Dr Eric Sherman from Memorial Sloan Kettering Cancer Center in New York City discusses recent therapeutic advances in thyroid cancer. CME information and select publications here.Av Research To Practice

Dr Jeffrey Zonder from Karmanos Cancer Institute in Detroit, Michigan discusses the biology, presentation and current management of AL amyloidosis and emerging data with novel therapies. CME information and select publications here.Av Research To Practice

Dr Ruben Mesa from the Mays Cancer Center in San Antonio, Texas, discusses therapeutic advances in the management of patients with myelofibrosis. CME information and select publications here.Av Research To Practice

Dr Toni Choueiri from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent therapeutic advances in the care of patients with renal cell carcinoma. CME information and select publications here.Av Research To Practice

Professor Arndt Vogel from Hannover Medical School in Germany discusses major clinical trials and recent changes in the treatment of advanced hepatocellular carcinoma. CME information and select publications [here]Av Research To Practice

Dr Eytan Stein from Memorial Sloan Kettering Cancer Center in New York City discusses novel agents and strategies in the treatment of acute myeloid leukemia. CME information and select publications here.Av Research To Practice

Dr Amy DeZern from The Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, discusses recent therapeutic advances in higher-risk myelodysplastic syndromes. CME information and select publications here.Av Research To Practice

Dr Rachna Shroff from the University of Arizona Cancer Center in Tucson, Arizona, discusses data and the practical implications from key gastrointestinal cancer presentations made at recent major oncology conferences. CME information and select publications here.Av Research To Practice

Dr Rebecca Heist from Massachusetts General Hospital Cancer Center in Boston, Massachusetts discusses recent therapeutic advances in the management of MET-altered non-small cell lung cancer. CME information and select publications here.Av Research To Practice

Dr Brady Stein from Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses recent therapeutic advances in myelofibrosis. CME information and select publications here.Av Research To Practice

Dr Pamela Kunz from the Yale Cancer Center in Palo Alto, California, discusses recent therapeutic advances in neuroendocrine tumors. CME information and select publications here.Av Research To Practice

Professor Axel Hauschild from Kiel University in Kiel, Germany, discusses recent therapeutic advances in the treatment of metastatic melanoma with BRAF mutations. CME information and select publications here.Av Research To Practice

Dr Justin Gainor from Massachusetts General Hospital in Boston, Massachusetts, discusses recent therapeutic advances in non-small cell lung cancer with RET fusions. CME information and select publications here.Av Research To Practice

Professor Sia Daneshmand from the USC/Norris Comprehensive Cancer Center in Los Angeles, California, discusses recent advances in and perspectives on the management of nonmetastatic urothelial bladder cancer. CME information and select publications here.Av Research To Practice

Dr Benjamin Levy from the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses recent therapeutic advances in the care of patients with small cell lung cancer. CME information and select publications here.Av Research To Practice

Dr Amrita Krishnan from City of Hope in Duarte, California, discusses recent therapeutic advances in BCMA-directed therapies for multiple myeloma. CME information and select publications here.Av Research To Practice

Dr Heather Wakelee from Stanford Cancer Institute in Palo Alto, California, discusses the management of localized non-small cell lung cancer. CME information and select publications here.Av Research To Practice

Dr Stephen Ansell from the Mayo Clinic in Rochester, Minnesota, reviews the evolution of the Hodgkin lymphoma treatment landscape. CME information and select publications here.Av Research To Practice

Dr Charles Powell from the Mount Sinai National Jewish Health Respiratory Institute in New York discusses the diagnosis and treatment of interstitial lung disease in patients receiving anticancer therapy. CME information and select publications here.Av Research To Practice

Dr Mansoor Raza Mirza from Copenhagen University Hospital in Copenhagen, Denmark, discusses recent therapeutic advances in the care of patients with endometrial cancer. CME information and select publications here.Av Research To Practice

Dr Asim Farooq from The University of Chicago Medical Center in Chicago, Illinois, discusses common ocular toxicities associated with anticancer agents, including antibody-drug conjugates and EGFR, ALK, MEK and BRAF inhibitors. CME information and select publications here.Av Research To Practice

Dr Joshua Sabari from the Perlmutter Cancer Center in New York discusses key presentations in lung cancer from the 2022 ASCO annual meeting. CME information and select publications here.Av Research To Practice

Dr Alexander Spira of the Virginia Cancer Specialists Research Program in Fairfax, Virginia, discusses recent therapeutic advances in the care of patients with non-small cell lung cancer with KRAS mutations. CME information and select publications here.Av Research To Practice

Dr Brian Slomovitz from the Mount Sinai Medical Center in Miami, Florida, discusses key abstracts in gynecologic cancers presented at the 2022 ASCO annual meeting. CME information and select publications here.Av Research To Practice

Dr Ezra Cohen from the Moores Cancer Center at UC San Diego Health in La Jolla, California, discusses key abstracts presented in head, neck and thyroid cancers at the 2022 ASCO annual meeting. CME information and select publications here.Av Research To Practice

Dr Shanu Modi from Memorial Sloan Kettering Cancer Center in New York discusses recent therapeutic advances in HER2-low breast cancer. CME information and select publications here.Av Research To Practice

Dr Jeffrey Bradley from the Emory University School of Medicine in Atlanta, Georgia, and Dr David Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss the past, present and future management of unresectable Stage III non-small cell lung cancer. CME information and select publications here.…

Dr Sandy Srinivas from Stanford University in California discusses key abstracts across genitourinary cancers presented at the 2022 ASCO annual meeting. CME information and select publications here.Av Research To Practice

Professor Juan Valle from The Christie NHS Foundation Trust in Manchester, United Kingdom, discusses the evolving treatment landscape in biliary tract cancers. CME information and select publications here.Av Research To Practice

Dr Angela DeMichele from the University of Pennsylvania in Philadelphia discusses key abstracts in breast cancer presented at the 2022 ASCO annual meeting. CME information and select publications here.Av Research To Practice

Dr Adam Brufsky from the UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania, discusses recent data in HER2-low breast cancer. CME information and select publications here.Av Research To Practice

Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses recent advances and future directions in the treatment of patients with follicular lymphoma. CME information and select publications here.Av Research To Practice

Dr David O’Malley from The Ohio State University and The James Cancer Center in Columbus, Ohio, discusses trials in ovarian cancer presented at SGO 2022. CME information and select publications here.Av Research To Practice

Dr Judy Garber from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent data with PARP inhibitors for breast cancer. CME information and select publications here.Av Research To Practice

Dr Mark Agulnik from City of Hope in Duarte, California, discusses recent therapeutic advances in soft tissue sarcoma. CME information and select publications here.Av Research To Practice